Quanterix Corporation Quanterix Corporation

Quanterix Corporation

QTRX

Rank in Stocks #17676
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences... Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.
Share Price
$3.38
Last synced: 2026-11-09
Market Cap
$159.85M
Change (1 day)
16.75%
Change (1 year)
-41.11%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Quanterix Corporation (QTRX)
Operating Margin as of November 2026 TTM: -86.19%
According to Quanterix Corporation's latest financial reports, its current operating margin (TTM) is -86.19%. At the end of 2025 the company had an operating margin of -79.20%.
Operating Margin history for Quanterix Corporation from 2015 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -86.19% 8.83%
2025 -79.20% 103.86%
2024 -38.85% 2.32%
2023 -37.97% -61.57%
2022 -98.81% 93.29%
2021 -51.12% 39.79%
2020 -36.57% -50.12%
2019 -73.32% -12.55%
2018 -83.84% -26.26%
2017 -113.69% -7.91%
2016 -123.46% 3.54%
2015 -119.24% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
15.24% -100.18%
US
18.08% -100.21%
IE
21.25% -100.25%
US
21.05% -100.24%
US
28.09% -100.33%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Quanterix Corporation's operating margin

What is Quanterix Corporation's operating margin?

Quanterix Corporation's operating margin is -86.19%, as of Nov 2026.

What was Quanterix Corporation's operating margin in 2025?

In 2025, Quanterix Corporation's operating margin was -79.20%, compared with -38.85% in 2024.

How has Quanterix Corporation's operating margin changed since 2020?

From 2020 to 2025, Quanterix Corporation's operating margin was highest in 2020 (-36.57%) and lowest in 2022 (-98.81%).

How does Quanterix Corporation's operating margin compare with similar companies?

Quanterix Corporation's operating margin (-86.19%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.